Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2018-03-20 | 2018-11-22 | 43501 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2020-01-08 | 2020-03-09 | 102543 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2020-03-27 | 2020-04-02 | 109675 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2020-09-30 | 2020-10-13 | 125332 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2022-04-29 | 2022-05-27 | 159695 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2022-08-11 | 2022-09-30 | 166442 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2023-06-02 | 2023-06-23 | 193611 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2023-07-13 | 2023-10-15 | 198473 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2024-03-27 | 2024-04-05 | 223552 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2024-06-20 | 2024-08-02 | 231010 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2024-09-12 | 2024-09-27 | 237360 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2024-10-18 | 2024-12-20 | 240613 |
| APO-BENZYDAMINE ORAL RINSE | 0.15% | LIQUID | Actual shortage | 2017-08-13 | 2017-10-05 | 19087 |
| APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-03-10 | 2017-04-03 | 67 |
| APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-09-04 | 2018-08-23 | 20860 |
| APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2020-09-09 | 2020-09-28 | 123892 |
| APO-BILASTINE TABLETS | 20MG | TABLET | Resolved | 2025-03-20 | 2025-04-11 | 253067 |
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-01-03 | 2018-09-09 | 34835 |
| APO-BISACODYL SUP 10MG | 10MG | SUPPOSITORY | Actual shortage | 2017-08-13 | 2017-10-05 | 18985 |
| APO-BISOPROLOL | 5MG | TABLET | Resolved | 2017-07-26 | 2017-12-14 | 17208 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |